IMRN Company Profile and Key Details
Immuron Limited
IMRN Stock Price Chart
Stock Price Today
Immuron Limited (IMRN) stock surged +0.96%, trading at $2.10 on NASDAQ, up from the previous close of $2.08. The stock opened at $2.00, fluctuating between $1.99 and $2.10 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It markets Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and reduce the symptoms of minor gastro-intestinal disorders, as well as for dietary supplement for digestive tract protection; and Protectyn, an immune supplement to maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III clinical trials to reduce the risk of contracting travelers' diarrhea, as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529, which is in clinical development stage focuses on treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and ETEC infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is based in Carlton, Australia.
Company Information
| Employees | 7 |
| Beta | 1.17 |
| Sales or Revenue | $4.90M |
| 5Y Sales Change% | -0.986% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Immuron Limited (NASDAQ: IMRN) stock price is $2.10 in the last trading session. During the trading session, IMRN stock reached the peak price of $2.10 while $1.99 was the lowest point it dropped to. The percentage change in IMRN stock occurred in the recent session was 0.96% while the dollar amount for the price change in IMRN stock was $0.02.
The NASDAQ listed IMRN is part of Biotechnology industry that operates in the broader Healthcare sector. Immuron Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. David Lyon
Head of Marketing
Dr. Jerry Kanellos Ph.D.
Chief Operating Officer
Dr. Dan Ruben Peres
Chief Medical Officer
Mr. Steven George Lydeamore CPA, CPA, M.B.A., MBA
Chief Executive Officer
Mr. Flavio Palumbo
Chief Commercial Officer
IMRN's closing price is 27.27% higher than its 52-week low of $1.65 where as its distance from 52-week high of $5.96 is -64.77%.
Number of IMRN employees currently stands at 7.
Official Website of IMRN is: https://www.immuron.com.au
IMRN could be contacted at phone 613 982 45254 and can also be accessed through its website. IMRN operates from 25-37 Chapman Street, Carlton, VIC 3130, Australia.
IMRN stock volume for the day was 2.56K shares. The average number of IMRN shares traded daily for last 3 months was 12.09K.
The market value of IMRN currently stands at $11.97M with its latest stock price at $2.10 and 228M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com